MindCotine uses VR to help users stop smoking, launches a crowdfunding campaign
The program combines mindfulness practices, psychological therapies and community engagement to combat nicotine addiction.
Magellan Health, Click Therapeutics team-up to launch a mobile-enabled smoking cessation program
The all-in-one solution will combine Magellan's clinical coaching and pharmacy benefit management capabilities with Click's machine learning platform.
Smoking cessation app making it easier to order GSK nicotine patches
Under the deal, those using 2morrow's SmartQuit app as part of an employer program will be able to more easily get GSK's nicotine replacement therapy.
Small trial demonstrates the effectiveness of Chrono Therapeutics’ smoking cessation tech
When compared to subjects treated with placebo, test subjects had a statistically significant and clinically meaningful reduction in cravings.
2Morrow’s smoking cessation app SmartQuit heading to Turkey
Together with mHealth Technologies, 2Morrow will localize the SmartQuit app to help about 14 million people in Turkey (as of 2013) kick the habit.
Chrono Therapeutics receives second Fast Track SBIR grant from the NCI
The award of up to $2.3M will support final product development of the digital portion of Chrono's patient-individualized smoking cessation therapy.
This smart cigarette case wants to help smokers kick the habbit
Stemming from the Engineering Entrepreneurs Program at North Carolina State University, the project recently launched an Indiegogo crowdfunding campaign.
Rock Health backs Chrono Therapeutics’ smoking cessation wearable
The company makes the SmartStop device which is worn on the arm or body, and used as a drug (nicotine) delivery tool that works with a companion mobile app.
Kosmo’s smart e-cigarette helps quit smoking
Set to ship in September, Kosmo's smart e-cig boasts an LED Smartlight to show progress on the user's daily smoking goal. They are looking to raise 30,000 EUR.
Chrono Therapeutics secures $32 million to further develop its smoking cessation technology
The Series A round was raised from a number of investors, including Canaan Partners, 5AM Ventures, Fountain Healthcare Partners, Mayo Clinic and GE Ventures.